Contact us

Visualize a scientific publication and its results

Why Medical Adviser`s Group?
  • Quality
    All works are performed in accordance with generally accepted international recommendations for the creation of scientific medical content. are a leading firm in providing quality and value to our customers.
  • Expertise
    The expertise of our employees is confirmed by the high-profile scientific journal New England Journal of Medicine
  • Development
    Our company is a finalist of the international scientific contest SPRINT Data Analysis Challenge member of our team has at least 5 years of legal experience method allows us to achieve success in problems of all levels.
  • Flexibility
    We have several scientific editors in our team who specialize in various therapeutic areas and several medical writers; thus, we can replace the specialist at any time, which ensures the project consistency

Let's have a conversation

We will get back in touch with you
 I agree to the terms and conditions and privacy policy
  • About us
  • Services
  • Medical writing
  • Trainings
  • Medical presentations
  • Data visualization
Visual storytelling for medical publications

Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

#Mepolizumab reduced the number of exacerbations in #urban #children with exacerbation-prone eosinophilic #asthma, #MUPPITS2 study finds

https://bit.ly/3plfXTy
#VisualAbstract #DataViz #USA #eosinophilicasthma #in
2022-08-22 16:56